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Abstract
Background: Disseminated infection and bacteraemia is an underreported and under-researched aspect of Johne’s
disease. This is mainly due to the time it takes for Mycobacterium avium subsp. paratuberculosis (MAP) to grow and
lack of sensitivity of culture. Viable MAP cells can be detected in the blood of cattle suffering from Johne’s disease
within 48 h using peptide-mediated magnetic separation (PMMS) followed by bacteriophage amplification. The aim
of this study was to demonstrate the first detection of MAP in the blood of experimentally exposed cattle using the
PMMS-bacteriophage assay and to compare these results with the immune response of the animal based on serum
ELISA and shedding of MAP by faecal culture.
Results: Using the PMMS-phage assay, seven out of the 19 (37 %) MAP-exposed animals that were tested were
positive for viable MAP cells although very low numbers of MAP were detected. Two of these animals were positive
by faecal culture and one was positive by serum ELISA. There was no correlation between PMMS-phage assay results
and the faecal and serum ELISA results. None of the control animals (10) were positive for MAP using any of the four
detection methods. Investigations carried out into the efficiency of the assay; found that the PMMS step was the
limiting factor reducing the sensitivity of the phage assay. A modified method using the phage assay directly on
isolated peripheral blood mononuclear cells (without PMMS) was found to be superior to the PMMS isolation step.
Conclusions: This proof of concept study has shown that viable MAP cells are present in the blood of MAP-exposed
cattle prior to the onset of clinical signs. Although only one time point was tested, the ability to detect viable MAP in the
blood of subclinically infected animals by the rapid phage-based method has the potential to increase the understanding
of the pathogenesis of Johne’s disease progression by warranting further research on the presence of MAP in blood.
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Background
Mycobacterium avium subsp. paratuberculosis (MAP) is
a slow-growing bacterium that causes Johne’s disease, a
wasting disease in ruminants and other animals. A com-
mon test for Johne’s disease is the serum antibody ELISA
test which monitors the humoral immune response of the
animal following MAP exposure. However there are well
known limitations of this test, for example the sensitivity
can be extremely low, especially during subclinical stages
of infection [1]. It has been established that there can be a
bacteraemic phase in paratuberculosis, which has been
demonstrated by both PCR [2] and culture [3, 4]. However
the PCR cannot differentiate between live and dead cells
and the sensitivity of the PCR assay is limited by inhibitory
substances in the blood and the likelihood of there being a
low number of MAP cells present [5]. However, studies
that have compared the detection of MAP in blood by
PCR to ELISAs have found an association but poor corre-
lations between the tests [5, 6]. The long periods of time
required for culture of this organism (even using auto-
mated systems) means that to date very few studies of
blood samples have been completed so that the incidence,
intensity and duration of mycobacteraemia is not known
in any animal species.
We have previously described the use of a rapid,
bacteriophage-based method (phage amplification assay)
coupled with PMMS to specifically detect and identify vi-
able MAP cells in the blood of naturally infected animals
[7]. The organism was detected in milk and serum ELISA
positive animals, but not from a certified Johne’s disease
free herd that was milk and serum ELISA negative. The
PMMS-phage method was employed here as components
present in the whole blood inhibited the phage assay to
such as extent that the sensitivity of the assay was not use-
ful [7]. Using PMMS it was possible the capture the MAP
cells and suspend them in a medium suitable for the
phage assay. The stages of natural infection are difficult to
ascertain in naturally infected cattle and given the known
limitations of the ELISA tests for diagnosis of early infec-
tion this was not surprising, but it means that more data
is needed to understand the relationship between bacterial
load during mycobacteraemia and the blood ELISA re-
sults. The aim of this investigation was to apply the
PMMS-phage assay to determine whether MAP could be
detected in the blood of experimentally exposed cattle,
where their stage of infection could be defined. Previously
we have demonstrated that the MAP cells are found
within the PMBC fraction of blood [7], and we have de-
fined this as bacteraemia even though the MAP cells are
intracellular rather than free in the blood stream. It is also
possible that the assay would also detect MAP cells free in
the bloodstream but to date we have not formally tested
this possibility. The presence of viable MAP in cattle
blood has previously been demonstrated in serum ELISA
positive, inconclusive and negative animals by the PMMS-
phage assay in an uncontrolled environment [7], thus the
significance of mycobacteraemia is unknown, when com-
pared to tests that are insensitive when used on subclin-
cally infected animals, such as the ELISA test. As it can be
assumed that the presence of this organism in the blood
of the animal indicates that it has crossed the gut and
disseminated, the results would be used to determine if
evidence of disseminated infection correlates with the re-
corded immune response of an animal in a controlled
environment.
Results
Use of the blood assay on MAP-exposed, subclinically
infected cattle
During our study, none of the animals had weight loss or
signs related to Johne’s disease. Blood samples were col-
lected at 4 years, 8 months post-exposure from all animals
for the PMMS-phage assay. Faecal and blood samples
were collected in the same month for faecal culture, PCR
and serum antibody ELISA testing. The unexposed cohort
remained MAP-negative as determined by faecal culture,
serum Ab ELISA and faecal PCR (Table 1) by the end of
the experiments. One of the exposed animals (#14) was
euthanized due to reasons unrelated to MAP status. Sam-
ples from two of the control animals (#3 and #10) pro-
duced plaques, however none of these gave a positive
result when the IS900 PCR was performed, indicating that
these plaques represented either breakthrough (incom-
plete inactivation of all extracellular phage particles results
in M. smegmatis plaques) or detection of a mycobacter-
ium other than MAP [8]. Therefore the phage results
agreed with all other tests performed in the negative con-
trol herd. Thus none of the control animals were positive
for MAP by any of the methods used.
Two of the inoculated animals (#17 and 23) were
shedding MAP in their faeces, according to the results
of both faecal culture and faecal PCR. Animal #23 was
also positive by serum Ab ELISA and animal #17 gave a
borderline positive serum Ab ELISA (49 %; cut-off value
for a positive test result = 55 %). Using the phage-PCR
MAP assay, seven out of the 19 (37 %) MAP-exposed
animals that were tested had positive results, indicating
that viable MAP cells were detected in their blood sam-
ples. However compared to other studies we have
performed, only very low numbers of plaques (2–5) were
produced in the MAP-positive samples. Interestingly an-
imals #20 and #27, which were positive for the presence
of MAP in their blood according to the PMMS-phage
assay, had the next two highest (36 % and 41 %, respect-
ively, although classed as negative) serum ELISA test
results (Table 1). However there was no overall correl-
ation between the results of phage-PCR and either faecal
PCR or serum Ab ELISA.
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Investigation of PMMS MAP isolation efficiency
As the number of MAP cells detected using the
PMMS-phage assay was much lower than recorded in
our previous studies [7], the efficiency of the PMMS
isolation step was investigated. Cattle strains of MAP
were 10-fold serially diluted from 1 × 104 to 1 × 100
viable MAP cells. These cells were inoculated in 7H9
medium and the PMMS method to isolate the MAP
cells was carried out. The phage enumeration assay
was then used to determine how many MAP cells
were captured from the samples. It was found that
for this batch of peptide-coated beads the limit of de-
tection of the MAP cells was only 7.3 × 102 pfu.ml−1
(Table 2). This indicated that the PMMS MAP isola-
tion method was only isolating roughly 10 % of the
MAP cells present in the samples, thus explaining the
low levels of plaques recorded in in the blood of
MAP-positive samples.
Table 1 Results from the PMMS-phage assay, faecal culture, faecal PCR and serum ELISA for sub-clinical, experimentally exposed
cattle to MAP
Results
Sample Breed MAP exposure statusa PMMS-Phage assayb Faecal culture Faecal PCRc Serum Ab ELISA (%)d
1 Holstein Control - (0) - - 1.00
2 Holstein Control - (0) - - 29.34
3 Holstein Control - (2) - - 3.85
4 Holstein Control - (0) - - 5.92
5 Holstein Control - (0) - - 5.42
6 Holstein Control - (0) - - 3.14
7 Holstein Control - (0) - - 17.49
8 Holstein Control - (0) - - 10.49
9 Red/Holstein Control - (0) - - 3.50
10 Red/Holstein Control - (3) - - 4.57
11 Holstein Inoculated - (0) - - 2.57
12 Holstein Inoculated + (2) - * 3.28
13 Holstein Inoculated - (0) - - 5.00
14 Holstein Inoculated #e #e #e #e
15 Holstein Inoculated - (5) - - 14.49
16 Holstein Inoculated + (5) - - 3.28
17 Holstein Inoculated - (0) + + 48.68
18 Holstein Inoculated + (2) - - 8.57
19 Holstein Inoculated - (0) - - 6.21
20 Holstein Inoculated + (2) - - 35.62
21 Holstein Inoculated - (2) - - 12.63
22 Holstein Inoculated - (0) - - 3.50
23 Holstein Inoculated - (0) + + 118.77
24 Holstein Inoculated - (0) - - 6.50
25 Holstein Inoculated - (0) - * 4.64
26 Red/Holstein Inoculated + (4) - - 5.21
27 Holstein Inoculated + (5) - * 41.11
28 Holstein Inoculated - (0) - - 2.00
29 Red/Holstein Inoculated + (3) - - 13.28
30 Red/Holstein Inoculated - (0) - * 1.50
aInoculated – animals experimentally exposed to MAP; Control – animals not
exposed to MAP
b+/- indicates result of combined PMMS-phage –PCR assay. Plaque numbers
for each sample given in brackets
c* indicates MAP DNA was detected but the quantity detected was below the cut-point for a positive result [16]
dSerum Ab ELISA (IDEXX); Positive value > 55 %, suspected value 45–55 %
e# Animal 14 was culled due to other illness unrelated to Johne’s disease before sample collection
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Improving the detection of MAP by applying the phage
assay to PBMCs isolated from blood
Since the PMMS step requires expensive reagents and
optimisation of bead coating, experiments were designed
to determine whether MAP cells could be detected from
whole blood without using PMMS. It has previously
been shown that MAP cells are present in the PBMC’s
of the blood and not found in the plasma or red blood
cell fractions [7]. Initially, simple limit of detection ex-
periments were performed to determine whether the
PBMCs inhibited the phage assay. MAP cells were
enumerated using the method described by [9] and arti-
ficially spiked into modified 7H9 medium and the
PBMCs isolated from sheep blood. The phage assay was
carried out on the artificially inoculated PBMCs and
modified 7H9 medium containing known numbers of
MAP cells. The results show that there was no signifi-
cant difference (p < 0.05) in the number of MAP cells
detected by the phage assay in the control samples (con-
taining only modified 7H9 medium) and in the PBMCs.
Duplicate blood samples tested with the PMMS-phage
assay and phage assay without PMMS on PBMCs. The
paired samples tested independently with the phage
assay, the detection of MAP in PBMCs was more repro-
ducible (R2 = 0.92; Fig. 1b) than isolating MAP cells
using the PMMS method on whole blood samples and
detecting with the phage assay (R2 = 0.54; Fig. 1a).
Discussion
Cattle infected with MAP may not show clinical signs of
disease until years after exposure. Subclinically infected
animals may shed MAP into the environment in their
faeces and MAP cells can also be present in their milk,
but both milk and blood ELISA testing on subclinical
animals is notoriously insensitive [10, 11]. It is not
known whether all animals that give a positive ELISA
test result will go on to develop clinical Johne’s disease.
The results of this study show the first application of the
phage assay on experimentally infected animals and its
comparison between faecal shedding and blood ELISA
status. The results have shown that animals with variable
blood ELISA status can have detectable levels of viable
MAP in their blood. More data are required to better
understand the relationship between the host immune
response following MAP-exposure and disease progres-
sion, however having a clearly defined experimentally
controlled study such as this is the first step in deter-
mining the usefulness of the phage assay. The ability to
be able to detect MAP cells in blood samples from ani-
mals and obtain results within days (rather than within
months), may aid the understanding of disseminated in-
fection with regards to immune responses during disease
progression and development of clinical disease and
when this moves beyond a localised gut infection to a
systemic phase.
It is also important to consider the type of bacteraemia
detected in this study. As demonstrated here and previ-
ously, MAP can be detected in the PBMC fraction of
blood and not others [7], so it is assumed that the MAP
cells detected are internalised within PBMCs. In our ex-
periments to establish the internalisation model, free
MAP cells did not co-purify with the PBMCs supporting
this model. The possibility exists however that bacter-
aemic animals have free MAP cells present in their
blood that were not detected by our methods.
There were a number of differences in experimental
design compared to a previous study in which we found
viable MAP cells in whole blood ranging from 3–39
pfu.ml−1 [7]. The assay used in the present study was
transferred from University of Nottingham laboratory,
where the assay was initially established and optimised,
to the University of Sydney. The availability of different
equipment and the use of different reagents (particularly
the peptide-coated beads) meant that some aspects of
the method were not fully optimised before the trial was
carried out. Furthermore, the animals in this study were
castrated males and therefore were not exposed to the
same reproductive and lactation stress as the milking
dairy cattle used in the previous study [12]. These fac-
tors may explain the differences in the plaque number
results obtained between the two studies.
The PMMS method requires expensive reagents, such
as biotinylated peptides and paramagnetic beads and the
use of PMMS introduced more variability into the re-
sults gained as tested with paired samples. Using the
well-established Ficoll-Paque method to separate PBMCs
from whole blood removes the need for PMMS and
means that the phage assay can be carried out directly,
reducing losses during sample processing. However this
does reduce the selectivity of the method and therefore
other mycobacteria potentially present in the blood may
also be detected by the phage assay. This means that
there is a greater reliance on the performance of the
end-point PCR identification step to confirm the identity
of the cell detected by the phage. Although limited by
Table 2 Efficiency of phage-PMMS method in isolating and
detecting MAP cells compared to MPN
Number of MAP Cells
MPN Number of Plaques
104 TNTC TNTC TNTC
103 88 52 79
102 0 5 4
101 0 0 0
100 0 0 0
MPN most probable number method for determining number of MAP cells [22]
TNTC too numerous to count
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the inefficiency of the PMMS, the results showed that
the assay was specific; despite plaques being detected in
two of the unexposed animals, no MAP DNA was de-
tected in these samples, which probably represents some
phage break-through in the assay. This has been noted
before and emphasises the importance of combining the
phage assay with a subsequent PCR-identification step.
In the group of exposed cattle, exposure to MAP oc-
curred over 4.5 years before blood samples were taken for
testing and none of the cattle were showing clinical signs
of Johne’s disease. Approximately one third of MAP-
exposed cattle had viable MAP in their blood that was de-
tectable by the PMMS-phage assay. Although two animals
were shedding MAP in their faeces, no MAP was detected
in the blood of these individuals. This was interesting as it
would have been assumed, if the disease had progressed
to the stage of detectable level of shedding, that the ani-
mals would be more likely to have viable MAP in their
blood. However the results suggested that this was not ne-
cessarily the case. In subclinically infected animals espe-
cially, faecal shedding is intermittent. This study examined
a single time-point and only small volumes of blood were
tested. It is also important to note that bacteraemia is a
transient event that can happen during any stage of infec-
tion, whether that is in the early subclinical stage of infec-
tion or later [13]. Thus, these findings may indicate that
the presence of viable MAP cells in the blood may also be
intermittent relative to when the animals are found to be
shedding MAP in their faeces or may be a rare event or
may be the different forms MAP are found in the blood
may relate to different pathophysiological manifestations
that may or may not be related to the lack of correlation
between faecal shedding and dissemination into the blood
stream. Thus testing additional aliquots from a single time
point may assist in determining the true likelihood of de-
tecting viable MAP in the blood.
Fig. 1 Reproducibility of detecting MAP from whole blood using PMMS and from PBMCs. Figure show the reproducibility of detecting viable
MAP cells using paired samples tested independently with the phage assay using the PMMS to isolate the MAP cells from whole blood (a) or
detecting the MAP cells with the phage assays directly from PBMCs isolated from sheep blood (b)
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Conclusions
This is the first study to show that viable MAP may be
present in the blood of experimentally MAP-exposed
cattle prior to the onset of clinical signs and does not
appear to be correlated to other measures, including fae-
cal shedding and serum antibody responses, which are
routine diagnostics used for Johne’s. The ability to detect
viable MAP in the blood of subclinically infected ani-
mals may lead to increased sensitivity of diagnosis in the
early stages of infection, but this requires validation.
Here we have demonstrated the proof of concept in a
controlled study where variations such as exposure (time
and dose etc.) and environmental factors are limited
[14]. Having a tool like the phage assay allows new ques-
tions to be asked possibly in a longitudinal study testing
the blood, milk and faeces of animals to enable a better
understanding of paratuberculosis disease progression,
determine when systemic infection occurs in animals,
and how this influences the serum and milk ELISAs, and
faecal culture or PCR results.
Methods
Bacterial strains, bacteriophage and growth medium
To optimise MAP detection in the peripheral blood
mononuclear cells (PBMCs), MAP strains K10 and
ATCC 19698 were used. The Mycobacterium smegmatis
strain was mc2155, which is used routinely in phage as-
says [15] and the bacteriophage used was D29. All liquid
cultures of MAP were prepared in modified 7H9/OADC
medium (Becton Dickenson, UK) supplemented with
Mycobactin J (2 μg μl-1; Synbiotics Corporation, France)
and when performing the phage assay the medium was
supplemented with 2 mM CaCl2. MAP strain; CM00/
416 was used to both establish the phage assay method
in the University of Sydney laboratories and to infect
the cattle. MAP strains used for experimental infec-
tion trials and for the investigation of peptide medi-
ated magnetic separation (PMMS) isolation efficiency
were grown as previously described by Plain [16] and
enumerated using the most probable number method
(MPN) as described by [17].
Experimentally infected animals and sampling
All animal experiments carried out for this study were
approved by The University of Sydney, Australia, animal
ethics committee. An existing MAP infection trial being
undertaken at the University of Sydney was used to pro-
vide samples for analysis (manuscript in preparation). In
this trial 30 calves (aged 2–4 months) were age matched
then randomly allocated into a group of 20 to be experi-
mentally exposed to MAP (Numbers; 11–30, Table 1)
along with a group of 10 age-matched unexposed con-
trol animals (Numbers; 1–10, Table 1). With consent,
male Holstein and Holstein/Australian Red cross calves
were selected from a property in New South Wales that
was unexposed to MAP; there was no previous history
of any MAP infection on the farm and both the dams
and calves were confirmed to be MAP-negative by faecal
culture and faecal PCR. The MAP exposure time points
were determined using a previous study [18]. Calves at
3-4 months of age were experimentally inoculated orally
with a cattle (C) strain of MAP (CM00/416/C4) using a
protocol based on a validated ovine model [19]. The in-
oculation was carried out in three doses over a period of
one month with the total dose of viable MAP adminis-
tered being 9.46 × 109 MAP cells. The control unex-
posed group consisted of 10 age-matched calves, and
exposed and unexposed cohorts were maintained in dif-
ferent paddocks at the University of Sydney Camden
farms to prevent cross-contamination. Control animals
were maintained on paddocks where no MAP-infected
livestock had been housed in the past. Faecal MAP cul-
ture was performed as previously described [20]. All
samples tested and presented in this study were obtained
from the animals 4 years, 8 months post exposure to
allow the potential for MAP infection to establish. Faecal
PCR was performed using a validated method as previ-
ously described [16] and serum antibody ELISA and
results were expressed as signal of the test sample as a
proportion of the positive control, corrected for the
negative control (S/P %) calculated as described by the
manufacturer (IDEXX Laboratories, Maine, USA).
Peptide mediated magnetic MAP isolation and phage
detection from blood
MAP cells were isolated from blood and detected using
the phage assay using PMMS according to the method
described by [7]. Briefly, magnetic beads were coated
with peptides aMp3 and aMptD that specifically bind
MAP [21]. Coated beads were mixed with 1 ml of whole
blood diluted in 9 ml of modified 7H9 medium (10 ml
total volume). Samples were mixed for 30 min to allow
MAP to bind the beads before they were recovered by
centrifugation (4500 × g; 15 min) and washed with 9 ml
of modified 7H9 medium before recovered with centri-
fugation before being resuspended in 1 ml of modified
7H9 medium to carry out the magnetic separation.
Beads were then concentrated by magnetic separation
and resuspended in 1 ml of modified 7H9 medium prior
to testing using the phage amplification assay.
The phage assay and experimental controls were
carried out according to [15]. Briefly, 1 ml samples were
mixed with D29 bacteriophage (100 μl; 1 × 109 pfu.ml−1)
in modified 7H9 Media and incubated for 1 h to allow
the phage infection. Any remaining free phage were
inactivated using 10 mM (final concentration) ferrous
ammonium sulphate (6 min at room temperature whilst
being continuously mixed). The ferrous ammonium
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sulphate was then inactivated with 5 ml of modified 7H9
medium before the samples were mixed with M. smeg-
matis cells (1 ml; 1 × 108 pfu.ml−1) before plating with
soft 7H10 agar (0.75 % agar). The number of MAP cells
detected was determined by counting the number of pla-
ques formed (data reported as pfu.ml−1) in the lawn of
M. smegmatis cells. Enumeration of MAP cells in initial
inocula was performed by diluting samples until count-
able numbers of plaques are obtained [9].
PCR identification of MAP cells
After the phage assay, DNA from up to five plaques
formed on each plate was extracted using a gel DNA ex-
traction kit (ZymoResearch, UK). Then the nested IS900
PCR assay was used to confirm that MAP DNA was
present as described previously by [7]. The MAP specific
IS900 quantitative PCR was carried out using the
method described by [16].
Peripheral blood mononuclear cells isolation
The isolation of the PBMCs from cattle blood was car-
ried out using Ficoll-Paque Plus according to the manu-
facturer’s instructions (GE Healthcare Life Sciences,
UK). Briefly 2 ml of whole heparinised blood was mixed
with 2 ml of PBS (Dulbecco A). This was carefully lay-
ered on 3 ml of Ficoll-Paque Plus in 15 ml falcon tubes.
The samples were centrifuged (400 × g, for 30 min at 18
oC). After centrifugation the upper layer (plasma) of the
sample was removed. The buffy coat layer was carefully
removed ensuring the red blood cells were not dis-
turbed. The PBMCs were washed with 6 ml of PBS by
centrifugation (100 × g for 10 min at 18 oC). The super-
natant was removed and the pellet was resuspended in
1 ml of modified 7H9 medium for the phage assay.
Abbreviations
MAP, Mycobacterium avium subsp. paratuberculosis; MPN, most probable
number; PMMS, peptide-mediated magnetic separation
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